NexGel, Inc. is a provider of healthcare, beauty, and over-the-counter products, including ultra-gentle, high-water-content hydrogels. It is engaged in manufacturing high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. It specializes in custom gels by capitalizing on proprietary manufacturing technologies. Its Nexgel segment comprises the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. Its CG labs segment comprises the CG Converting and Packaging, LLC used for the Company’s converting and packaging business, which is based in Granbury, Texas. Its hydrogel consumer products are marketed under the brand names MedaGel and LumaGel Beauty. Its brands include Silverseal, Hexagels, Turfguard, Kenkoderm, and Dermablock. It also specializes in eye and eyelash consumer products.
Ticker SymbolNXGLW
Company nameNexgel Inc
IPO dateDec 22, 2021
CEOMr. Adam Levy
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
Address2150 Cabot Blvd West,
CityLANGHORNE
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code19047
Phone12157028550
Websitehttps://nexgel.com/
Ticker SymbolNXGLW
IPO dateDec 22, 2021
CEOMr. Adam Levy
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data